https://www.sciencedaily.com/news/mind_brain/dementia/ Read the latest medical research on dementia. Causes, symptoms, lowering the risks, care, medications and new treatments for dementia. en-us Sun, 19 Apr 2026 00:06:58 EDT Sun, 19 Apr 2026 00:06:58 EDT 60 https://www.sciencedaily.com/images/scidaily-logo-rss.png https://www.sciencedaily.com/news/mind_brain/dementia/ For more science news, visit ScienceDaily. https://www.sciencedaily.com/releases/2026/04/260414075648.htm A lifetime of mental stimulation—like reading, writing, and learning new skills—may help protect the brain as we age. People with the highest levels of cognitive enrichment had a much lower risk of Alzheimer’s and experienced symptoms years later than those with the lowest levels. Wed, 15 Apr 2026 04:09:05 EDT https://www.sciencedaily.com/releases/2026/04/260414075648.htm https://www.sciencedaily.com/releases/2026/04/260414075633.htm Loneliness may quietly affect how well older adults remember things—but it might not be speeding up mental decline after all. A large European study tracking over 10,000 people for seven years found that those who felt lonelier started off with weaker memory, yet their memory didn’t deteriorate any faster than those who felt more socially connected. The findings challenge the idea that loneliness directly accelerates cognitive decline or dementia, suggesting instead that it impacts baseline brain performance. Tue, 14 Apr 2026 08:56:31 EDT https://www.sciencedaily.com/releases/2026/04/260414075633.htm https://www.sciencedaily.com/releases/2026/04/260411043048.htm Losing your sense of smell might signal Alzheimer’s far earlier than expected. Scientists found that immune cells in the brain actively destroy smell-related nerve fibers after detecting abnormal signals on their surfaces. This damage begins in early stages of the disease, well before cognitive decline. The discovery could help identify at-risk patients sooner and improve treatment timing. Sat, 11 Apr 2026 08:13:19 EDT https://www.sciencedaily.com/releases/2026/04/260411043048.htm https://www.sciencedaily.com/releases/2026/04/260409101111.htm Alzheimer’s isn’t just one problem—it’s a tangled mix of biology, aging, and overall health. That’s why drugs targeting a single factor have fallen short, even as new treatments show modest benefits. Scientists are now pushing toward multi-pronged strategies, from gene editing to brain-cell rejuvenation and gut health interventions. The goal: stop treating Alzheimer’s as one disease and start tackling it as a complex system. Fri, 10 Apr 2026 10:12:15 EDT https://www.sciencedaily.com/releases/2026/04/260409101111.htm https://www.sciencedaily.com/releases/2026/04/260408225933.htm Scientists have uncovered a surprising new player in Alzheimer’s disease: a protein called CSE that helps produce tiny amounts of hydrogen sulfide gas in the brain. In experiments with genetically engineered mice, removing this protein led to memory loss, brain damage, and other hallmarks of Alzheimer’s, including weakened blood-brain barriers and reduced formation of new neurons. The findings suggest that this “rotten egg” gas, when carefully regulated, may actually protect brain cells and support memory. Wed, 08 Apr 2026 22:59:33 EDT https://www.sciencedaily.com/releases/2026/04/260408225933.htm https://www.sciencedaily.com/releases/2026/04/260407073850.htm Vitamin D levels in midlife may play a bigger role in long-term brain health than previously thought. In a study following nearly 800 people over 16 years, those with higher vitamin D levels in their 30s and 40s had lower levels of tau protein later on, a key marker linked to dementia. Tue, 07 Apr 2026 07:47:09 EDT https://www.sciencedaily.com/releases/2026/04/260407073850.htm https://www.sciencedaily.com/releases/2026/04/260406192922.htm Scientists at Oregon State University have captured something researchers have long struggled to see: the real-time chemical interactions that help drive Alzheimer’s disease. By watching how metal ions—especially copper—trigger harmful protein clumping in the brain, the team uncovered a clearer picture of how the disease develops at a molecular level. Tue, 07 Apr 2026 07:37:31 EDT https://www.sciencedaily.com/releases/2026/04/260406192922.htm https://www.sciencedaily.com/releases/2026/04/260401071931.htm A surprising new study suggests that genetics may change how diet affects brain health—especially when it comes to Alzheimer’s risk. Researchers found that older adults carrying high-risk APOE gene variants didn’t show the expected cognitive decline if they ate relatively high amounts of meat. In fact, those with these genes who consumed the most meat had slower cognitive decline and lower dementia risk, challenging conventional dietary advice. Thu, 02 Apr 2026 13:54:07 EDT https://www.sciencedaily.com/releases/2026/04/260401071931.htm https://www.sciencedaily.com/releases/2026/03/260323005526.htm Scientists have uncovered a hidden “death switch” in the brain that may be driving Alzheimer’s disease—and even found a way to turn it off in mice. The culprit is a toxic pairing of two proteins that, when combined, triggers the destruction of brain cells and fuels memory loss. By using a new compound to break apart this deadly duo, researchers were able to slow disease progression, protect brain cells, and even reduce hallmark amyloid buildup. Mon, 23 Mar 2026 05:34:10 EDT https://www.sciencedaily.com/releases/2026/03/260323005526.htm https://www.sciencedaily.com/releases/2026/03/260318033138.htm Your morning coffee or tea could be quietly supporting your brain health. A long-term study found that moderate consumption of caffeinated coffee or tea was linked to an 18% lower risk of dementia and better cognitive performance over time. The benefits appeared strongest at 2–3 cups of coffee or 1–2 cups of tea daily—and even held true for people genetically predisposed to dementia. Wed, 18 Mar 2026 06:47:36 EDT https://www.sciencedaily.com/releases/2026/03/260318033138.htm https://www.sciencedaily.com/releases/2026/03/260317064457.htm A key Alzheimer’s drug has finally revealed its secret. Researchers discovered that lecanemab works by activating the brain’s immune cells—but only through a specific part of the antibody called the Fc fragment. This piece acts like a trigger, prompting microglia to clear harmful amyloid plaques. The finding could reshape how future Alzheimer’s therapies are designed. Tue, 17 Mar 2026 07:44:52 EDT https://www.sciencedaily.com/releases/2026/03/260317064457.htm https://www.sciencedaily.com/releases/2026/03/260312020104.htm A new study suggests Alzheimer’s disease may be detectable through subtle shape changes in proteins found in the blood. Researchers discovered that structural differences in three blood proteins closely track the progression of the disease. By analyzing these changes in more than 500 people, the team was able to distinguish healthy individuals from those with mild cognitive impairment or Alzheimer’s with impressive accuracy. The approach could help move diagnosis and treatment to earlier stages. Thu, 12 Mar 2026 07:00:56 EDT https://www.sciencedaily.com/releases/2026/03/260312020104.htm https://www.sciencedaily.com/releases/2026/03/260311004720.htm Scientists have developed a promising new approach to treating Alzheimer’s disease by turning ordinary brain cells into powerful plaque-clearing machines. Instead of requiring frequent antibody infusions like current therapies, the experimental treatment uses genetically engineered astrocytes — abundant support cells in the brain — that are equipped with a CAR “homing device” similar to those used in cancer immunotherapy. Wed, 11 Mar 2026 17:01:42 EDT https://www.sciencedaily.com/releases/2026/03/260311004720.htm https://www.sciencedaily.com/releases/2026/03/260307155945.htm Scientists have uncovered a surprising new role for little-known brain cells called tanycytes that may influence the development of Alzheimer’s disease. These specialized cells appear to help remove toxic tau protein from the brain by transporting it from the cerebrospinal fluid into the bloodstream. When tanycytes become damaged or dysfunctional, tau can accumulate in the brain, a hallmark of Alzheimer’s. Sun, 08 Mar 2026 06:14:34 EDT https://www.sciencedaily.com/releases/2026/03/260307155945.htm https://www.sciencedaily.com/releases/2026/03/260303145730.htm A new study has uncovered why some brain cells are more resistant to Alzheimer’s damage than others. Researchers found a natural cleanup system that helps remove toxic tau protein before it can form harmful clumps. The study also shows that cellular stress can produce a dangerous tau fragment linked to Alzheimer’s. Strengthening the brain’s natural defenses could point the way to new treatments. Tue, 03 Mar 2026 21:38:45 EST https://www.sciencedaily.com/releases/2026/03/260303145730.htm https://www.sciencedaily.com/releases/2026/02/260228093505.htm Scientists at Rice University have produced the first full, dye-free molecular atlas of an Alzheimer’s brain. By combining laser-based imaging with machine learning, they uncovered chemical changes that spread unevenly across the brain and extend beyond amyloid plaques. Key memory regions showed major shifts in cholesterol and energy-related molecules. The findings hint that Alzheimer’s is a whole-brain metabolic disruption—not just a protein problem. Sun, 01 Mar 2026 10:16:01 EST https://www.sciencedaily.com/releases/2026/02/260228093505.htm https://www.sciencedaily.com/releases/2026/02/260225081205.htm Worrying about getting older—especially fearing future health problems—may actually speed up aging at the cellular level, according to new research from NYU. In a study of more than 700 women, those who felt more anxious about aging showed signs of faster biological aging in their blood, measured using cutting-edge “epigenetic clocks.” Fears about declining health had the strongest link, while concerns about beauty or fertility didn’t appear to have the same biological impact. Thu, 26 Feb 2026 08:14:43 EST https://www.sciencedaily.com/releases/2026/02/260225081205.htm https://www.sciencedaily.com/releases/2026/02/260224023159.htm Subtle changes in brain blood flow and oxygen use are closely linked to hallmark signs of Alzheimer’s, including amyloid plaques and memory-related brain shrinkage. Simple, noninvasive scans may one day help spot risk earlier—by looking at the brain’s vascular health, not just its plaques. Tue, 24 Feb 2026 10:21:58 EST https://www.sciencedaily.com/releases/2026/02/260224023159.htm https://www.sciencedaily.com/releases/2026/02/260222085203.htm Scientists have created a blood test that can estimate when Alzheimer’s symptoms are likely to begin. By measuring a protein called p-tau217, the model predicts symptom onset within roughly three to four years. The protein mirrors the silent buildup of amyloid and tau in the brain long before memory loss appears. This advance could speed up preventive drug trials and eventually guide personalized care. Mon, 23 Feb 2026 06:46:07 EST https://www.sciencedaily.com/releases/2026/02/260222085203.htm https://www.sciencedaily.com/releases/2026/02/260221000321.htm A common bacterium best known for causing pneumonia and sinus infections may also play a surprising role in Alzheimer’s disease. Researchers found that Chlamydia pneumoniae can invade the retina and brain, where it sparks inflammation, nerve cell death, and the buildup of amyloid-beta—the hallmark protein linked to Alzheimer’s. Higher levels of the bacterium were found in people with Alzheimer’s, especially those carrying the high-risk APOE4 gene, and were tied to more severe cognitive decline. Sat, 21 Feb 2026 00:43:23 EST https://www.sciencedaily.com/releases/2026/02/260221000321.htm https://www.sciencedaily.com/releases/2026/02/260219040752.htm Exercise may sharpen the mind by repairing the brain’s protective shield. Researchers found that physical activity prompts the liver to release an enzyme that removes a harmful protein causing the blood-brain barrier to become leaky with age. In older mice, dialing down this protein reduced inflammation and improved memory. The discovery points to a surprising body-to-brain pathway that could inspire new Alzheimer’s therapies. Fri, 20 Feb 2026 10:19:43 EST https://www.sciencedaily.com/releases/2026/02/260219040752.htm https://www.sciencedaily.com/releases/2026/02/260217005759.htm A major new study has spotlighted three familiar medicines that could take on an unexpected new role in the fight against Alzheimer’s disease — with a shingles vaccine emerging as the front-runner. After reviewing 80 existing drugs, an international panel of experts identified Zostavax, Viagra (sildenafil), and riluzole as the most promising candidates for repurposing. Wed, 18 Feb 2026 07:02:28 EST https://www.sciencedaily.com/releases/2026/02/260217005759.htm https://www.sciencedaily.com/releases/2026/02/260215225555.htm Researchers have identified two brain receptors that help the brain clear away amyloid beta, a hallmark of Alzheimer’s disease. By stimulating these receptors in mice, scientists increased levels of a natural amyloid-breaking enzyme, reduced buildup in the brain, and improved memory-related behavior. Because these receptors are common drug targets, the findings could open the door to affordable pill-based treatments with fewer side effects. Tue, 17 Feb 2026 05:30:08 EST https://www.sciencedaily.com/releases/2026/02/260215225555.htm https://www.sciencedaily.com/releases/2026/02/260215084954.htm Scientists have created the most detailed maps yet of how genes control one another inside the brains of people with Alzheimer’s disease. Using a powerful new AI-based system called SIGNET, the team uncovered cause-and-effect relationships between genes across six major brain cell types, revealing which genes are truly driving harmful changes. The most dramatic disruptions were found in excitatory neurons, where thousands of genetic interactions appear to be extensively rewired as the disease progresses. Sun, 15 Feb 2026 09:15:19 EST https://www.sciencedaily.com/releases/2026/02/260215084954.htm https://www.sciencedaily.com/releases/2026/02/260212025620.htm A newly identified protein may hold the key to rejuvenating aging brain cells. Researchers found that boosting DMTF1 can restore the ability of neural stem cells to regenerate, even when age-related damage has set in. Without it, these cells struggle to renew and support memory and learning. The findings raise hopes for treatments that could slow or even reverse aspects of brain aging. Thu, 12 Feb 2026 09:42:41 EST https://www.sciencedaily.com/releases/2026/02/260212025620.htm https://www.sciencedaily.com/releases/2026/02/260211073023.htm A simple brain-training program that sharpens how quickly older adults process visual information may have a surprisingly powerful long-term payoff. In a major 20-year study of adults 65 and older, those who completed five to six weeks of adaptive “speed of processing” training — along with a few booster sessions — were significantly less likely to develop dementia, including Alzheimer’s disease, even two decades later. Participants who received the boosted speed training had a 25% lower dementia risk compared to those who received no training, making it the only intervention in the trial to show such a lasting protective effect. Wed, 11 Feb 2026 22:15:24 EST https://www.sciencedaily.com/releases/2026/02/260211073023.htm https://www.sciencedaily.com/releases/2026/02/260206012213.htm Scientists have uncovered promising clues that compounds found in Aloe vera could play a role in fighting Alzheimer’s disease. Using advanced computer modeling, researchers discovered that beta-sitosterol—a natural plant compound—strongly interacts with two key enzymes involved in memory loss and cognitive decline. The compound showed stability, strong binding, and favorable safety indicators, making it a standout candidate for future drug development. Sun, 08 Feb 2026 07:57:41 EST https://www.sciencedaily.com/releases/2026/02/260206012213.htm https://www.sciencedaily.com/releases/2026/02/260203030540.htm A massive Swedish study tracking nearly 28,000 people for 25 years found an unexpected link between full-fat dairy and brain health. Among adults without a genetic risk for Alzheimer’s, eating more full-fat cheese was associated with a noticeably lower risk of developing the disease, while higher cream intake was tied to reduced dementia risk overall. The findings challenge decades of low-fat dietary advice but come with important caveats. Wed, 04 Feb 2026 09:44:17 EST https://www.sciencedaily.com/releases/2026/02/260203030540.htm https://www.sciencedaily.com/releases/2026/02/260201062459.htm When the brain rests, it usually replays recent experiences to strengthen memory. Scientists found that in Alzheimer’s-like mice, this replay still occurs — but the signals are jumbled and poorly coordinated. As a result, memory-supporting brain cells lose their stability, and the animals struggle to remember where they’ve been. Sun, 01 Feb 2026 10:41:29 EST https://www.sciencedaily.com/releases/2026/02/260201062459.htm https://www.sciencedaily.com/releases/2026/01/260126231847.htm A new genetic study suggests that obesity and high blood pressure may play a direct role in causing dementia, not just increasing the risk. By analyzing data from large populations in Denmark and the U.K., researchers found strong evidence that higher body weight can damage brain health over time, especially when it leads to elevated blood pressure. Much of the dementia risk appeared to be tied to vascular damage in the brain, which affects blood flow and cognitive function. Mon, 26 Jan 2026 23:18:47 EST https://www.sciencedaily.com/releases/2026/01/260126231847.htm https://www.sciencedaily.com/releases/2026/01/260125083413.htm Alzheimer’s may destroy memory by flipping a single molecular switch that tells neurons to prune their own connections. Researchers found that both amyloid beta and inflammation converge on the same receptor, triggering synapse loss. Surprisingly, neurons aren’t passive victims—they actively respond to these signals. Targeting this receptor could offer a new way to protect memory beyond current amyloid-focused drugs. Mon, 26 Jan 2026 03:08:27 EST https://www.sciencedaily.com/releases/2026/01/260125083413.htm https://www.sciencedaily.com/releases/2026/01/260124003829.htm Researchers have found that a natural aging-related molecule can repair key memory processes affected by Alzheimer’s disease. The compound improves communication between brain cells and restores early memory abilities that typically fade first. Because it already exists in the body and declines with age, boosting it may offer a safer way to protect the brain. The discovery hints at a new strategy for slowing cognitive ageing before severe damage sets in. Sun, 25 Jan 2026 02:17:02 EST https://www.sciencedaily.com/releases/2026/01/260124003829.htm https://www.sciencedaily.com/releases/2026/01/260122093435.htm A new study reveals that super agers over 80 have a distinct genetic edge. They are much less likely to carry the gene most associated with Alzheimer’s risk, even when compared with other healthy seniors. Researchers also found higher levels of a protective gene variant in this group. Together, the findings help explain why some people age with remarkably youthful minds. Thu, 22 Jan 2026 09:41:30 EST https://www.sciencedaily.com/releases/2026/01/260122093435.htm https://www.sciencedaily.com/releases/2026/01/260122073623.htm Alzheimer’s may be driven far more by genetics than previously thought, with one gene playing an outsized role. Researchers found that up to nine in ten cases could be linked to the APOE gene — even including a common version once considered neutral. The discovery reshapes how scientists think about risk and prevention. It also highlights a major opportunity for new treatments aimed at a single biological pathway. Fri, 23 Jan 2026 10:16:38 EST https://www.sciencedaily.com/releases/2026/01/260122073623.htm https://www.sciencedaily.com/releases/2026/01/260121034130.htm New research suggests that consistent aerobic exercise can help keep your brain biologically younger. Adults who exercised regularly for a year showed brains that appeared nearly a year younger than those who didn’t change their habits. The study focused on midlife, a critical window when prevention may offer long-term benefits. Even small shifts in brain age could add up over decades. Thu, 22 Jan 2026 01:51:37 EST https://www.sciencedaily.com/releases/2026/01/260121034130.htm https://www.sciencedaily.com/releases/2026/01/260116035348.htm Researchers have identified OTULIN, an immune-regulating enzyme, as a key trigger of tau buildup in the brain. When OTULIN was disabled, tau vanished from neurons and brain cells remained healthy. The findings challenge long-held assumptions about tau’s necessity and highlight a promising new path for fighting Alzheimer’s and brain aging. Scientists now believe OTULIN may act as a master switch for inflammation and age-related brain decline. Fri, 16 Jan 2026 03:53:48 EST https://www.sciencedaily.com/releases/2026/01/260116035348.htm https://www.sciencedaily.com/releases/2026/01/260114084107.htm A massive international brain study has revealed that memory decline with age isn’t driven by a single brain region or gene, but by widespread structural changes across the brain that build up over time. Analyzing thousands of MRI scans and memory tests from healthy adults, researchers found that memory loss accelerates as brain tissue shrinkage increases, especially later in life. While the hippocampus plays a key role, many other brain regions also contribute, forming a broad vulnerability rather than isolated damage. Wed, 14 Jan 2026 09:56:10 EST https://www.sciencedaily.com/releases/2026/01/260114084107.htm https://www.sciencedaily.com/releases/2026/01/260113220915.htm Despite longstanding guidelines, many dementia patients are still prescribed brain-altering medications that can raise the risk of falls and confusion. A new study shows that while prescribing has decreased overall, people with cognitive impairment remain more likely to receive these drugs. In many cases, there was no documented medical justification. The results suggest that medication safety remains a serious concern in dementia care. Tue, 13 Jan 2026 23:17:46 EST https://www.sciencedaily.com/releases/2026/01/260113220915.htm https://www.sciencedaily.com/releases/2026/01/260112001041.htm Researchers have discovered a brain activity pattern that can predict which people with mild cognitive impairment are likely to develop Alzheimer’s disease. Using a noninvasive brain scanning technique and a custom analysis tool, they detected subtle changes in electrical signals tied to memory processing years before diagnosis. The findings point to a new way of spotting Alzheimer’s early—by listening directly to how neurons behave. Mon, 12 Jan 2026 09:24:19 EST https://www.sciencedaily.com/releases/2026/01/260112001041.htm https://www.sciencedaily.com/releases/2026/01/260103155026.htm Your daily rhythm may matter more for brain health than previously thought. Older adults with weaker, more disrupted activity patterns were far more likely to develop dementia than those with steady routines. A later daily energy peak was also linked to higher risk. The study points to the body clock as a possible early warning sign for cognitive decline. Sat, 03 Jan 2026 19:52:00 EST https://www.sciencedaily.com/releases/2026/01/260103155026.htm https://www.sciencedaily.com/releases/2025/12/251228020016.htm Researchers discovered that clogged brain “drains” show up early in people at risk of Alzheimer’s disease. These blockages, easily seen on standard MRI scans, are tied to toxic protein buildup linked to memory loss and cognitive decline. In some cases, they may signal Alzheimer’s earlier than other commonly used brain markers. This could help physicians detect the disease earlier, before irreversible damage sets in. Sat, 03 Jan 2026 00:45:11 EST https://www.sciencedaily.com/releases/2025/12/251228020016.htm https://www.sciencedaily.com/releases/2025/12/251225235946.htm A new study suggests the vagus nerve may be one of the heart’s most important defenders against aging. Researchers found that keeping this nerve connected to the heart helps protect heart cells and maintain strong pumping ability. Even partial restoration of the nerve was enough to slow harmful changes in heart tissue. The discovery could reshape future heart and transplant surgeries. Thu, 01 Jan 2026 17:47:56 EST https://www.sciencedaily.com/releases/2025/12/251225235946.htm https://www.sciencedaily.com/releases/2025/12/251224032354.htm Alzheimer’s has long been considered irreversible, but new research challenges that assumption. Scientists discovered that severe drops in the brain’s energy supply help drive the disease—and restoring that balance can reverse damage, even in advanced cases. In mouse models, treatment repaired brain pathology, restored cognitive function, and normalized Alzheimer’s biomarkers. The results offer fresh hope that recovery may be possible. Wed, 24 Dec 2025 10:14:26 EST https://www.sciencedaily.com/releases/2025/12/251224032354.htm https://www.sciencedaily.com/releases/2025/12/251222080119.htm New research suggests Alzheimer’s may start far earlier than previously thought, driven by a hidden toxic protein in the brain. Scientists found that an experimental drug, NU-9, blocks this early damage in mice and reduces inflammation linked to disease progression. The treatment was given before symptoms appeared, targeting the disease at its earliest stage. Researchers say this approach could reshape how Alzheimer’s is prevented and treated. Mon, 22 Dec 2025 08:11:02 EST https://www.sciencedaily.com/releases/2025/12/251222080119.htm https://www.sciencedaily.com/releases/2025/12/251221091246.htm Eating full-fat cheese and cream may be associated with a lower risk of dementia, according to a large study that tracked people for more than 25 years. Those who consumed higher amounts of these foods developed dementia less often than those who ate little or none. Interestingly, low-fat dairy products did not show the same pattern. Researchers caution that the findings show an association, not cause and effect. Sun, 21 Dec 2025 23:52:31 EST https://www.sciencedaily.com/releases/2025/12/251221091246.htm https://www.sciencedaily.com/releases/2025/12/251218060615.htm Spending a few hours a week helping others may slow the aging of the brain. Researchers found that both formal volunteering and informal acts, like helping neighbors or relatives, were linked to noticeably slower cognitive decline over time. The benefits added up year after year and didn’t require a huge time commitment. Even modest, everyday helping packed a powerful mental payoff. Fri, 19 Dec 2025 10:08:36 EST https://www.sciencedaily.com/releases/2025/12/251218060615.htm https://www.sciencedaily.com/releases/2025/12/251210092019.htm Obesity accelerates the rise of Alzheimer’s-related blood biomarkers far more rapidly than previously recognized. Long-term imaging and plasma data show that obese individuals experience much faster increases in proteins linked to neurodegeneration and amyloid buildup. Surprisingly, blood tests detected these changes earlier than PET scans. The results point to obesity as a major, modifiable contributor to Alzheimer’s progression. Wed, 10 Dec 2025 12:23:51 EST https://www.sciencedaily.com/releases/2025/12/251210092019.htm https://www.sciencedaily.com/releases/2025/12/251208052804.htm Researchers discovered that a tiny structural feature of the enzyme GPX4 helps keep neurons safe. A rare mutation removes this protection, allowing harmful molecules to damage cell membranes and trigger early dementia. Mouse and cell studies showed changes resembling Alzheimer’s. Early tests to slow this damage give scientists new directions to explore. Tue, 09 Dec 2025 04:12:54 EST https://www.sciencedaily.com/releases/2025/12/251208052804.htm https://www.sciencedaily.com/releases/2025/12/251205045845.htm A large study found that people with impaired kidneys tend to have higher Alzheimer’s biomarkers, yet they don’t face a higher overall risk of dementia. For those who already have elevated biomarkers, kidney problems may speed up when symptoms appear. The findings show that kidney health can change how Alzheimer’s blood tests are read. Doctors may need to consider both organs to get a clearer picture. Fri, 05 Dec 2025 05:19:42 EST https://www.sciencedaily.com/releases/2025/12/251205045845.htm https://www.sciencedaily.com/releases/2025/12/251203004721.htm A unique vaccine rollout in Wales gave researchers an accidental natural experiment that revealed a striking reduction in dementia among seniors who received the shingles vaccine. The protective effect held steady across multiple analyses and was even stronger in women. Evidence also suggests benefits for people who already have dementia, hinting at a therapeutic effect. Wed, 03 Dec 2025 10:22:27 EST https://www.sciencedaily.com/releases/2025/12/251203004721.htm https://www.sciencedaily.com/releases/2025/11/251130050712.htm Scientists have uncovered a stepwise system that guides how the brain sorts and stabilizes lasting memories. By tracking brain activity during virtual reality learning tasks, researchers identified molecules that influence how long memories persist. Each molecule operates on a different timescale, forming a coordinated pattern of memory maintenance. The discoveries reshape how scientists understand memory formation. Sun, 30 Nov 2025 06:13:16 EST https://www.sciencedaily.com/releases/2025/11/251130050712.htm https://www.sciencedaily.com/releases/2025/11/251128223748.htm Researchers found that repeated head impacts can disrupt a key system that helps the brain wash away waste. In professional fighters, this system initially seems to work harder after trauma, then declines over time. MRI scans revealed that these changes may show up years before symptoms do. The work could help identify at-risk athletes earlier in their careers. Fri, 28 Nov 2025 22:47:09 EST https://www.sciencedaily.com/releases/2025/11/251128223748.htm https://www.sciencedaily.com/releases/2025/11/251127010319.htm Scientists studying young adults with obesity discovered early indicators of brain stress that resemble patterns seen in cognitive impairment. The group showed higher inflammation, signs of liver strain and elevated neurofilament light chain, a marker of neuron injury. Low choline levels appeared closely tied to these changes. The results hint that early metabolic disruptions may quietly influence the brain long before symptoms emerge. Thu, 27 Nov 2025 02:45:12 EST https://www.sciencedaily.com/releases/2025/11/251127010319.htm https://www.sciencedaily.com/releases/2025/11/251126095023.htm Spermine, a small but powerful molecule in the body, helps neutralize harmful protein accumulations linked to Alzheimer’s and Parkinson’s. It encourages these misfolded proteins to gather into manageable clumps that cells can more efficiently dispose of through autophagy. Experiments in nematodes show that spermine also enhances longevity and cellular energy production. These insights open the door to targeted therapies powered by polyamines and advanced AI-driven molecular design. Thu, 27 Nov 2025 07:35:52 EST https://www.sciencedaily.com/releases/2025/11/251126095023.htm https://www.sciencedaily.com/releases/2025/11/251123115708.htm Hypertension begins harming the brain surprisingly early, even before measurable blood pressure increases. Key cells related to blood vessels, signaling, and myelin maintenance begin aging prematurely and malfunctioning. These disruptions resemble early patterns seen in cognitive decline and Alzheimer’s. Encouragingly, losartan reversed some of this early damage in mice. Mon, 24 Nov 2025 09:33:36 EST https://www.sciencedaily.com/releases/2025/11/251123115708.htm https://www.sciencedaily.com/releases/2025/11/251123085550.htm Researchers discovered that raising the protein Sox9 can help the brain’s astrocytes clear out toxic plaque buildup linked to Alzheimer’s. In mouse models that already showed memory problems, activating these cells improved cognitive performance. The treatment also reduced plaque levels over time. The work points toward a natural, cell-based way to slow Alzheimer’s decline. Sun, 23 Nov 2025 09:23:57 EST https://www.sciencedaily.com/releases/2025/11/251123085550.htm https://www.sciencedaily.com/releases/2025/11/251121090731.htm Researchers discovered that the common amino acid arginine can block harmful Aβ aggregation and reduce its toxic effects in Alzheimer’s disease models. In flies and mice, oral arginine lowered plaque levels, reduced inflammation, and improved behavior. Its strong safety record and low cost make it a promising repurposing candidate. The findings hint at a surprisingly simple path toward more accessible AD therapies. Fri, 21 Nov 2025 11:33:04 EST https://www.sciencedaily.com/releases/2025/11/251121090731.htm https://www.sciencedaily.com/releases/2025/11/251118220052.htm Scientists have developed a new molecule that breaks down beta-amyloid plaques by binding to excess copper in the brain. The treatment restored memory and reduced inflammation in rats, while also proving non-toxic and able to cross the blood–brain barrier. Because it’s far simpler and potentially cheaper than existing drugs, researchers are now pursuing partnerships to begin human trials. Wed, 19 Nov 2025 10:46:50 EST https://www.sciencedaily.com/releases/2025/11/251118220052.htm https://www.sciencedaily.com/releases/2025/11/251116105633.htm Older adults who regularly listen to or play music appear to have significantly lower risks of dementia and cognitive decline. The data suggests that musical engagement could be a powerful, enjoyable tool for supporting cognitive resilience in aging. Mon, 17 Nov 2025 09:31:10 EST https://www.sciencedaily.com/releases/2025/11/251116105633.htm https://www.sciencedaily.com/releases/2025/11/251115095914.htm Researchers found that tau proteins don’t jump straight into forming Alzheimer’s-associated fibrils—first they assemble into soft, reversible clusters. When the clusters were dissolved, fibril growth was almost entirely suppressed. This reveals a promising new strategy: stop the precursors, stop the disease. Sat, 15 Nov 2025 11:06:04 EST https://www.sciencedaily.com/releases/2025/11/251115095914.htm